StoneX Group
MENS icon

StoneX Group’s Jyong Biotech MENS Stock Holding History

StoneX Group’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$32.7K Buy
+15,248
New +$33.3K ﹤0.01% 1671

Other funds holding MENS

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
Bell Investment Advisors
Bell Investment Advisors Oakland, California $684M AUM 11.42% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

StoneX Group's MENS Position: Q3 2026 in Review

StoneX Group opened a new position in Jyong Biotech (MENS) in Q3 2026: 15,248 shares worth $32.7K. The stake represents ﹤0.01% of the portfolio and ranks #1671 among its holdings.

7 funds tracked by Wall St. Rank hold MENS as of Q3 2026.

  • StoneX Group held 15,248 shares of Jyong Biotech worth $32.7K as of Q3 2026.
  • Jyong Biotech was a new StoneX Group position in Q3 2026.
  • Jyong Biotech made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1671 holding.
  • 7 funds tracked by Wall St. Rank held Jyong Biotech as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.